• Most Popular
  • Most Shared

Merck probed over Vioxx marketing -WSJ

Thu Jan 31, 2008 9:18pm EST

Stocks

   

NEW YORK, Jan 31 (Reuters) - A federal grand jury is probing drug maker Merck & Co's (MRK.N) marketing for its pain drug Vioxx, the Wall Street Journal reported on its Web site on Thursday.

Stocks  |  Regulatory News

The U.S. attorney's office in Massachusetts is probing whether the company marketed Vioxx for uses other than those approved by regulators, the Journal reported, citing an unnamed source.

A representative for the U.S. attorney's office could not be reached immediately for comment. A Merck spokesman did not have an immediate comment. (Reporting by Paritosh Bansal; Editing by Gary Hill)

Stocks
Regulatory News


More from Reuters

Photo

Producer prices higher than expected

WASHINGTON (Reuters) - U.S. producer prices rose more than expected in November, lifted by a surge in energy costs, and recorded the first year-on-year gain since last November, according to a government report on Tuesday.

» More Top News
Iraq's Oil Minister Hussein al-Shahristani attends a tender in Baghdad June 30, 2009.REUTERS/Thaier al-Sudani

Ready for business

With enough oil deals on the table to quadruple its output capacity, Iraq is in a strong position when it enters quota talks with OPEC. But a number of challenges may unhinge its ambitious plans.  Full Article 

Commodities
In this photo reviewed by the U.S. Military, a guard leans on a fencepost as a Guantanamo detainee (L) jogs inside the exercise yard at Camp 5 detention center, at the U.S. Naval Base in Guantanamo Bay, January 21, 2009. REUTERS/Brennan Linsley/Pool

Life after Guantanamo

Critics are worried that Gitmo prisoners once dubbed "enemy combatants" will be using prisons as pulpits for anti-American rhetoric once they're moved to U.S. soil.  Full Article 

U.S.